osudhkosh

Generic

Tetanus (Human Anti-tetanus) Immunoglobulin

3 brands available in the market

At a glance

Tetanus (Human Anti-tetanus) Immunoglobulin is used for passive immunization against tetanus, particularly for post-exposure prophylaxis in patients with incomplete or uncertain immunization and for therapeutic treatment of tetanus.

Description

Tetanus Immunoglobulin is human plasma-derived immunoglobulin G (IgG) containing high-titer antibodies against tetanus toxoid. It neutralizes tetanus toxin, providing passive immunity and helping prevent tetanus infection.

Indications
  • Tetanus prophylaxis (post-injury in patients with incomplete or uncertain immunization)
  • Therapeutic treatment of tetanus
Therapeutic class

Vaccines, Anti-sera & Immunoglobulin

Pharmacological class

Passive Immunization

Pharmacology

Tetanus Immunoglobulin contains high-titer antibodies against tetanus toxoid that neutralize tetanus toxin. It provides immediate passive immunity, while adsorbed tetanus vaccine provides long-term active immunity.

Mechanism of action

Neutralizes tetanus toxin to provide passive immunity.

Dosage

Adult Dose (IM):

  • Post-exposure prophylaxis: 250 IU single dose
  • High-risk cases (infected wounds, deep/contaminated wounds, burns, tissue necrosis): 500 IU
  • Extensive burns: Second 250 IU dose after 36 hours
  • Tetanus treatment: 3,000-6,000 IU (with other clinical procedures)

Pediatric Dose (IM):

  • Post-exposure prophylaxis: 250 IU single dose
  • High-risk cases: 500 IU
  • Tetanus treatment: 3,000-6,000 IU
Administration
  • Intramuscular injection only; do not administer IV
  • Administer with tetanus vaccine using separate syringes at different sites
  • Observe for 20 minutes after administration
Missed dose

If you miss a dose, consult your doctor.

Side effects

Common Side Effects:

  • Injection site reactions (pain, tenderness)
  • Fever
  • Angioneurotic edema
  • Nephritic syndrome
  • Anaphylactic shock (rare)
Precautions & warnings
  • Caution in coagulation disorders or thrombocytopenia
  • Not for IV administration
  • Caution in pregnancy and lactation
  • Caution in patients with IgA deficiency and antibodies to IgA
Contraindications
  • Hypersensitivity in patients with IgA deficiency and concurrent antibodies to IgA
Drug interactions
  • May reduce the efficacy of live vaccines
Food interactions

Alcohol consumption is not relevant (injection).

Use in pregnancy

Use in Pregnancy: Safety not established in controlled trials; long-term clinical experience suggests no harmful effects on pregnancy, fetus, or neonate; consult your doctor.

Pregnancy Category: B — always consult a doctor before taking during pregnancy.

Use in lactation

Use in Lactation: Adequate information not available; consult your doctor.

Pediatric use

Indicated for children

Geriatric use

Indicated for elderly

Renal / hepatic impairment

Renal Impairment: Caution required; consult your doctor.

Hepatic Impairment: Caution required; consult your doctor.

Overdose effects

No overdose information; excessive doses may increase allergic reaction risk; provide symptomatic treatment.

Storage conditions

Store at 2-8°C in a refrigerator; do not freeze; protect from light; keep out of reach of children.

Chemical structure

Tetanus Immunoglobulin

Common questions

What does this injection do?
It provides immediate passive immunity against tetanus infection.
How to use it?
Given as IM injection by a healthcare professional.
What are the side effects?
Injection site pain, fever; rare anaphylactic reactions may occur.
⚠️ This information is for educational purposes only — not a substitute for medical advice. Consult a registered physician before taking any medicine.